Clinical studies recruiting near Grand Rapids

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Corewell Health Grand Rapids Hospitals - Helen DeVos Childre · National Cancer Institute (NCI) · NCT05099003 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Corewell Health Grand Rapids Hospitals - Helen DeVos Childre · National Cancer Institute (NCI) · NCT06172296 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Trinity Health Grand Rapids Hospital · NRG Oncology · NCT05624996 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Corewell Health Grand Rapids Hospitals - Helen DeVos Childre · Children's Oncology Group · NCT06368817 Registry for Stage 2 Type 1 Diabetes
Phase N/A · Corewell Health - Grand Rapids - Michigan Street Northeast- · Sanofi · NCT06481904 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Corewell Health Grand Rapids Hospitals - Helen DeVos Childre · National Cancer Institute (NCI) · NCT05691478 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Corewell Health Grand Rapids Hospitals - Helen DeVos Childre · Children's Oncology Group · NCT04322318 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Corewell Health Grand Rapids Hospitals - Butterworth Hospita · NRG Oncology · NCT05946213 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Corewell Health Grand Rapids Hospitals - Butterworth Hospita · NRG Oncology · NCT05174169 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Corewell Health Grand Rapids Hospitals - Butterworth Hospita · Alliance for Clinical Trials in Oncology · NCT06876714 Quality of End-of-Life Care for Children With Cancer
Phase N/A · Corewell Health Grand Rapids Hospitals - Helen DeVos Childre · Children's Oncology Group · NCT07412002 Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
NA · Corewell Health Grand Rapids Hospital · BrioHealth Solutions, Inc. · NCT06310031 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Corewell Health Grand Rapids Hospitals - Butterworth Hospita · National Cancer Institute (NCI) · NCT04269902 A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · Corewell Health Grand Rapids Hospitals - Helen DeVos Childre · Children's Oncology Group · NCT04293562 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Corewell Health Grand Rapids Hospitals - Butterworth Hospita · NRG Oncology · NCT06748222 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · Trinity Health Grand Rapids Hospital · NRG Oncology · NCT03180268 A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patien
Phase 3 · Corewell Health Grand Rapids Hospitals - Helen DeVos Childre · Children's Oncology Group · NCT05711667 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Alliance for Clinical Trials in Oncology · NCT04242095 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Corewell Health Grand Rapids Hospitals - Butterworth Hospita · National Cancer Institute (NCI) · NCT05256225 Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Phase 2 · Corewell Health Grand Rapids Hospitals - Butterworth Hospita · SWOG Cancer Research Network · NCT05633615 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · Corewell Health Grand Rapids Hospitals - Butterworth Hospita · National Cancer Institute (NCI) · NCT06498635 Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With G
Phase 2/Phase 3 · Corewell Health Grand Rapids Hospitals - Butterworth Hospita · ECOG-ACRIN Cancer Research Group · NCT07001748 Project: Every Child for Younger Patients With Cancer
Phase N/A · Corewell Health Grand Rapids Hospitals - Butterworth Hospita · Children's Oncology Group · NCT02402244 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Corewell Health Grand Rapids Hospitals - Butterworth Hospita · ECOG-ACRIN Cancer Research Group · NCT04566328 Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Phase 3 · Corewell Health Grand Rapids Hospitals - Butterworth Hospita · Children's Oncology Group · NCT05235165 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Corewell Health Grand Rapids Hospitals - Butterworth Hospita · NRG Oncology · NCT04852887 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With
Phase 3 · Corewell Health Grand Rapids Hospitals - Butterworth Hospita · National Cancer Institute (NCI) · NCT07198074 Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an An
Phase 3 · Corewell Health Grand Rapids Hospitals - Helen DeVos Childre · Children's Oncology Group · NCT06647953 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Corewell Health Grand Rapids Hospitals - Butterworth Hospita · National Cancer Institute (NCI) · NCT06058377 A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V60
Phase 2 · Helen DeVos Children's Hospital at Spectrum Health · SWOG Cancer Research Network · NCT04511013

Look up another city

Look up another condition